Sutro Biopharma, Inc. (STRO) Financials

STRO Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 194.5 million 297.8 million
March 31, 2026 242.0 million 308.9 million
Dec. 31, 2025 173.8 million 306.3 million
Sept. 30, 2025 209.7 million 296.9 million

STRO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -38.3 million 2.0 million
March 31, 2026 -42.3 million 1.6 million
Dec. 31, 2025 -26.6 million 1.7 million
Sept. 30, 2025 -38.4 million 1.6 million

STRO Net Income

No data available :(

STRO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 164.3 million - 10.8 million
March 31, 2026 202.6 million - 13.6 million
Dec. 31, 2025 141.4 million 219.5 million 7.9 million
Sept. 30, 2025 167.6 million - 17.7 million

STRO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 16.6 million
March 31, 2026 13.1 million
Dec. 31, 2025 8.6 million
Sept. 30, 2025 8.5 million

STRO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 31.7 million 7.8 million -
March 31, 2026 11000 36.6 million 7.6 million -
Dec. 31, 2025 184000 36.6 million 8.7 million -
Sept. 30, 2025 251000 39.9 million 8.7 million -

STRO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 9.8 million -
March 31, 2026 14.5 million 1.3 million
Dec. 31, 2025 11.6 million 1.6 million
Sept. 30, 2025 9.7 million 1.9 million

STRO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

STRO

Price: $22.28

52 week price:
7.15
43.85

Earnings Per Share: -17.37 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 223541

Market Capitalization: 339.6 million

Links: